She Offered to Help With Our Data. Then She Told Us Why It Mattered.
A few months ago, a woman from an AFib Facebook group reached out about Off Beat. She has a research background in health economics, and we got on a call so I could ask for her thoughts on how to collect more useful data.
She gave generous, practical feedback that made the survey better. But the clearer answer to why this project matters came from her own situation, not her advice on methodology. With her permission, I’m sharing parts of that conversation here, without identifying details.
Seven weeks post-ablation
At the time we spoke, she was seven weeks out from her second PFA ablation, inside the blanking period, and increasingly uncertain about the outcome.
“It’s a bit frustrating,” she said. “I’m already seven weeks from the second ablation and I’m still having episodes.”
Her AFib burden, the percentage of time her heart spends out of rhythm, had been sitting around 20%, roughly four hours a day, tracked through her Apple Watch.
“My heart rate goes to like 120, so it’s not that bad. I can do my regular things.”
Running had been less predictable. During one run, her heart rate jumped to 195 beats per minute in the final kilometre, confirmed by a chest strap monitor. The run had felt normal up to that point.
“Up to last week I never had problems running,” she said. “Then I started having problems, then I had a few good runs in the middle. I didn’t do anything different. It’s just very random.”
Limited research for younger patients
She pointed to a gap she’s run into directly: most AFib research focuses on older patients, often with multiple comorbidities. That makes sense given how much more common AFib is in that population, but it leaves younger patients with structurally healthy hearts working from data that doesn’t quite fit their situation.
“A lot of the research is about older patients with other health conditions,” she said. “My heart is structurally healthy, I’m active, and sometimes it’s hard to know how much of that research applies to someone like me.”
The questions she’s working through don’t have settled answers: how AFib progresses in younger patients, how many ablations are reasonable over a lifetime, how the condition and its treatment intersect with other major life decisions, including family planning.
She also raised a question that runs against some of the conventional framing in the field: whether AFib is inherently progressive, or whether that assumption mostly reflects data from older patients with decades more disease behind them. It’s not a question with a clear answer yet, particularly for patients her age.
Where treatment stands
She was on antiarrhythmic medication before her first ablation. It worked for a few months, then stopped.
“Right now I’m not on antiarrhythmic medication, but one of the things I’ll be discussing with my cardiologist is whether going back on medication makes sense while we work out the next steps.”
Still active, still figuring it out
Despite all of it, she’s still running, still working, and describes herself as managing well day to day. The hours of AFib happen alongside a full life rather than instead of one, which is a more accurate picture than how the condition is often portrayed.
We went into the call looking for input on data collection: validated questionnaires, longitudinal tracking, research ethics. We got useful answers on all of that, and a clearer sense of what sits behind the data: people making treatment decisions with incomplete information, asking questions the research hasn’t caught up to yet.
That’s part of why Off Beat exists, not as one person’s story, but as a way to help answer the questions that current research leaves open for people navigating AFib at a younger age.
If this experience sounds familiar, your data can help close that gap.
Off Beat is at offbeat.community
.